Andrew P. Rasdal, Executive Chairman of the Board at OBALON THERAPEUTICS INC (OBLN), bought 12,500 shares at $4.00 ($50K) on 2019-08-06, disclosed to the SEC on 2019-08-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.